J B Chemicals and Pharmaceuticals Ltd (JBCH)

Currency in INR
1,716.70
+1.20(+0.07%)
Closed·
JBCH Scorecard
Full Analysis
Has raised its dividend for 3 consecutive years
JBCH is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1,701.401,729.00
52 wk Range
1,385.752,030.00
Key Statistics
Bid/Ask
1,710.20 / 1,716.70
Prev. Close
1,715.5
Open
1,725
Day's Range
1,701.4-1,729
52 wk Range
1,385.75-2,030
Volume
74.24K
Average Volume (3m)
304.16K
1-Year Change
-12.8%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
JBCH Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high P/E ratio relative to near-term earnings growth
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Sell

J B Chemicals and Pharmaceuticals Ltd Company Profile

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company’s API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides dosage forms, such as tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, the company offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners; and contract manufacturing services. It provides its products to gastroenterology, anti-infectives, wound care, neonatology and pediatrics, gynaecology, dental, vitamins and minerals, hypertension, diabetes, nephrology, respiratory, pain-analgesic, dermatology, antivirals, lozenges, and contrast media and radio diagnostic therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Mumbai, India.

Employees
5304
Market
India

Compare JBCH to Peers and Sector

Metrics to compare
JBCH
Peers
Sector
Relationship
P/E Ratio
39.1x34.2x−0.5x
PEG Ratio
2.331.270.00
Price/Book
7.8x5.6x2.6x
Price / LTM Sales
6.7x5.4x3.3x
Upside (Analyst Target)
17.6%10.8%40.6%
Fair Value Upside
Unlock−6.0%5.3%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 44.06%
Dividend Yield
0.90%
Industry Median 0.74%
Annualised payout
15.50
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Jul 30, 2025
EPS / Forecast
13.70 / 13.20
Revenue / Forecast
10.94B / 11.09B
EPS Revisions
Last 90 days

JBCH Income Statement

People Also Watch

384.90
BAJE
-1.02%
6,116.50
KAYN
+0.93%
3,623.00
TORP
+0.14%
7,821.50
APLH
+0.17%
1,128.90
KFIN
+1.29%

FAQ

What Stock Exchange Does J.B. Chemicals&Pharma Trade On?

J.B. Chemicals&Pharma is listed and trades on the India National Stock Exchange stock exchange.

What Is the Stock Symbol for J.B. Chemicals&Pharma?

The stock symbol for J.B. Chemicals&Pharma is "JBCH."

What Is the J.B. Chemicals&Pharma Market Cap?

As of today, J.B. Chemicals&Pharma market cap is 268.22B.

What Is J.B. Chemicals&Pharma's Earnings Per Share (TTM)?

The J.B. Chemicals&Pharma EPS (TTM) is 44.06.

When Is the Next J.B. Chemicals&Pharma Earnings Date?

J.B. Chemicals&Pharma will release its next earnings report on 05 Nov 2025.

From a Technical Analysis Perspective, Is JBCH a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has J.B. Chemicals&Pharma Stock Split?

J.B. Chemicals&Pharma has split 2 times.

How Many Employees Does J.B. Chemicals&Pharma Have?

J.B. Chemicals&Pharma has 5304 employees.

What is the current trading status of J.B. Chemicals&Pharma (JBCH)?

As of 15 Aug 2025, J.B. Chemicals&Pharma (JBCH) is trading at a price of 1,716.70, with a previous close of 1,715.50. The stock has fluctuated within a day range of 1,701.40 to 1,729.00, while its 52-week range spans from 1,385.75 to 2,030.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.